WARNING: Market Shock Imminent

Join us on September 29 at 4 p.m. ET at the Market Shock 2022 event to find out what’s coming and how to profit.

Thu, September 29 at 4:00PM ET
 
 
 
 

VERU Stock Pops on Clinical Trial Update

  • Veru (VERU) stock is jumping on clinical trial news.
  • That includes its Covid-19 treatment meeting endpoints.
  • This has it expecting approval from the U.S. Food and Drug Administration (FDA).
Family of four looking sad during lockdown representing veru stock.

Source: Sam Wordley / Shutterstock.com

Veru (NASDAQ:VERU) stock is on the move Wednesday after the oncology-focused biopharmaceutical company published results from its Phase 3 clinical trial of sabizabulin.

Sabizabulin is Veru’s treatment to help patients suffering from Covid-19. Specifically, it’s designed to treat those with moderate to severe Covid-19 that are at high risk for acute respiratory distress syndrome and death.

According to Veru, sabizabulin met its primary endpoint of clinically and statistically meaningful reduction of death in treated patients compared to a placebo. That resulted in a 55.2% relative reduction in deaths in the intent-to-treat population.

To go along with this, sabizabulin was also successful in meeting its secondary endpoints. That includes the effects of sabizabulin treatment on mortality and the relative reduction of days in ICU treatment.

Alan Skolnick, M.D., principal investigator with HD Research, said this about the clinical trial results.

“We have battled this pandemic for two and a half years now, and we are still in desperate need for an effective treatment like sabizabulin to significantly reduce deaths in hospitalized COVID-19 patients. It’s in the hospital that we have the last real opportunity to prevent deaths from COVID-19 infection.”

Veru is anticipating authorization from the U.S. Food and Drug Administration (FDA) for sabizabulin. This has it scaling up production in preparation for that.

VERU stock is up 10.2% as of Wednesday afternoon.

There’s more stock news worth jumping into below!

We’ve got all the latest stock news traders need to know about! Among that is what has shares of Teladoc Health (NYSE:TDOC), Inspira Technologies (NASDAQ:IINN), and SCWorx (NASDAQ:WORX) stock moving today. You can find out all about that at the following links!

More Stock Market News for Wednesday

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.


Article printed from InvestorPlace Media, https://investorplace.com/2022/07/veru-stock-pops-on-clinical-trial-update/.

©2022 InvestorPlace Media, LLC